Maxidex

Dexamethasone, the active ingredient in Maxidex, is a corticosteroid (glucocorticoid) presented as an ophthalmic solution for ocular use. It treats postoperative ocular inflammation, uveitis, allergic conjunctivitis and other inflammatory eye conditions.\n\nGNH India supplies Maxidex as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Maxidex (dexamethasone) is a glucocorticoid ophthalmic solution used to manage inflammatory eye conditions.\n\n- Post‑operative ocular inflammation: reduces swelling, pain and redness after eye surgery.\n- Uveitis: controls intra‑ocular inflammation and helps prevent tissue damage.\n- Allergic conjunctivitis: alleviates redness, itching and swelling caused by allergic reactions.

Adverse reactions may occur with ocular use of dexamethasone.\n\nCommon Side Effects:\n- Blurred vision: transient visual disturbance after instillation.\n- Ocular irritation: burning or stinging sensation.\n- Increased intra‑ocular pressure: may develop with prolonged use.\n- Cataract formation: accelerated lens opacity with chronic therapy.\n\nSerious or Rare Side Effects:\n- Secondary ocular infection: bacterial or fungal infection of the eye.\n- Severe allergic reaction: swelling, erythema or urticaria.\n- Glaucoma: rapid rise in intra‑ocular pressure leading to optic nerve damage.\n- Corneal ulcer or melting: tissue breakdown requiring urgent care.

Before using Maxidex, consider the following safety measures.\n\n- Monitor intra‑ocular pressure: patients with glaucoma risk should have regular pressure checks.\n- Limit duration: avoid long‑term use unless directed by an ophthalmologist.\n- Avoid in active infection: do not use if there is a viral, bacterial or fungal eye infection without supervision.\n- Use with caution in diabetes: systemic absorption may affect glucose control.\n- Store at room temperature: keep in the original container, protect from light and moisture.

Dexamethasone eye drops can interact with other ophthalmic agents.\n\nMajor Interactions (Avoid):\n- Systemic corticosteroids: additive systemic glucocorticoid effect may increase systemic side effects.\n- Anticholinergic eye drops: may reduce the anti‑inflammatory efficacy of dexamethasone.\n- Topical NSAID eye drops: combined use can raise risk of corneal melting.\n\nModerate Interactions (Monitor Closely):\n- Antiviral eye medications: monitor for possible reduced antiviral activity.\n- Beta‑blocker eye drops: may interfere with intra‑ocular pressure monitoring.